We are live on ! Find out more
BC

Bartlett & Co Portfolio holdings

AUM $6.16B
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+1.11%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.01B
AUM Growth
+$9.87M
Cap. Flow
-$3.72M
Cap. Flow %
-0.19%
Top 10 Hldgs %
23.45%
Holding
755
New
60
Increased
91
Reduced
196
Closed
39

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$16.5M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$2.6M
3
PEP icon
PepsiCo
PEP
+$2.38M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.31M
5
ABT icon
Abbott
ABT
+$2.24M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$16.9M
2
LH icon
Labcorp
LH
+$5.68M
3
PG icon
Procter & Gamble
PG
+$1.57M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.5M
5
DE icon
Deere & Co
DE
+$1.47M

Sector Composition

Rank Sector Weight
1 Financials 16.27%
2 Healthcare 13.62%
3 Technology 12.78%
4 Energy 12.39%
5 Consumer Staples 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBC
351
DELISTED
WABCO HOLDINGS INC.
WBC
$74K ﹤0.01%
+700
New +$67.7K
AGN
352
DELISTED
Allergan Inc
AGN
$74K ﹤0.01%
600
– –
AEP icon
353
American Electric Power
AEP
$73.7B
$72K ﹤0.01%
1,415
– –
CPB icon
354
Campbell Soup
CPB
$6.51B
$72K ﹤0.01%
1,610
– –
PHO icon
355
Invesco Water Resources ETF
PHO
$1.97B
$72K ﹤0.01%
2,700
– –
SABA
356
Saba Capital Income & Opportunities Fund II
SABA
$220M
$72K ﹤0.01%
4,450
– –
THOR
357
DELISTED
THORATEC CORPORATION
THOR
$72K ﹤0.01%
2,000
– –
AZN icon
358
AstraZeneca
AZN
$263B
$71K ﹤0.01%
1,100
+1,025
+1,367% +$66.2K
CLX icon
359
Clorox
CLX
$11.6B
$71K ﹤0.01%
808
+308
+62% +$27K
IIF
360
Morgan Stanley India Investment Fund
IIF
$210M
$71K ﹤0.01%
3,638
– –
DVN icon
361
Devon Energy
DVN
$51.9B
$70K ﹤0.01%
1,050
-100
-9% -$6.21K
XME icon
362
State Street SPDR S&P Metals & Mining ETF
XME
$4.05B
$70K ﹤0.01%
1,680
– –
JWN
363
DELISTED
Nordstrom
JWN
$69K ﹤0.01%
1,100
– –
PB icon
364
Prosperity Bancshares
PB
$8.77B
$69K ﹤0.01%
1,050
-100
-9% -$6.33K
BT
365
DELISTED
BT Group plc (ADR)
BT
$69K ﹤0.01%
2,150
-1,050
-33% -$34K
ASX icon
366
ASE Group
ASX
$80.8B
$68K ﹤0.01%
+12,175
New +$59.7K
AVGO icon
367
Broadcom
AVGO
$1.82T
$68K ﹤0.01%
+10,500
New +$61.5K
CHKP icon
368
Check Point Software Technologies
CHKP
$13.3B
$68K ﹤0.01%
+1,000
New +$66.1K
TSM icon
369
TSMC
TSM
$2.09T
$68K ﹤0.01%
3,410
+184
+6% +$3.29K
VIG icon
370
Vanguard Dividend Appreciation ETF
VIG
$111B
$68K ﹤0.01%
900
– –
AGZ icon
371
iShares Agency Bond ETF
AGZ
$553M
$67K ﹤0.01%
600
– –
BIDU icon
372
Baidu
BIDU
$35.8B
$67K ﹤0.01%
442
– –
CSTM icon
373
Constellium
CSTM
$3.96B
$67K ﹤0.01%
+2,280
New +$59.7K
HLF icon
374
Herbalife
HLF
$1.23B
$67K ﹤0.01%
+2,350
New +$77.6K
SKM icon
375
SK Telecom
SKM
$13.7B
$67K ﹤0.01%
+1,791
New +$65.3K
13 14
15
16 17

Similar funds

WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Bartlett & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Bartlett & Co held 755 positions worth $2.01B, up 0.49% from $2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Bartlett & Co's Q1 2014 filing shows 60 new, 91 increased, 196 reduced and 39 closed positions. Its largest new stake was Gilead Sciences: 210,557 shares worth $14.9M. The largest sale was McDonald's, an estimated $16.9M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Bartlett & Co's largest Q1 2014 buy was Gilead Sciences: 210,557 shares worth $14.9M.
  • Bartlett & Co added most to Schwab US Broad Market ETF in Q1 2014, an estimated $2.6M increase.
  • Bartlett & Co's biggest Q1 2014 reduction was McDonald's, cutting an estimated $16.9M.
  • Bartlett & Co fully exited Discovery, Inc. Series C Common Stock in Q1 2014, selling an estimated $168K.
  • Bartlett & Co's ten largest holdings make up 23% of its $2.01B portfolio in Q1 2014.
  • Bartlett & Co opened 60 new positions and closed 39 in Q1 2014.
  • Bartlett & Co's portfolio value rose 0.49% quarter-over-quarter to $2.01B.

Based on Bartlett & Co's 13F filing for Q1 2014, filed 5 May 2014.